April 15, 2026 12:00 ET | Source: HEYGEARS INC BOSTON, April 15, 2026 (GLOBE NEWSWIRE) -- From April 14-16, 2026, RAPID…
Company Honored for Its Critical Role as Master Government Aggregator® for Gula Tech’s Vendors RESTON, Va., April 15, 2026 (GLOBE…
MT. OLIVE, N.J., April 15, 2026 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (OTCID: VISL), a global…
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026 Halle (Saale) / Munich,…
April 15, 2026 01:00 ET | Source: BioVersys BASEL, Switzerland, April 15, 2026 (GLOBE NEWSWIRE) -- Poster presentations to feature…
REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for…
PORTLAND, Ore., April 14, 2026 (GLOBE NEWSWIRE) -- As AI draws new attention to geometry, one challenge remains unresolved: turning…
Jama Connect once again recognized as the best requirements management software by G2's Grid® Methodology April 14, 2026 11:00 ET…
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- TRUEiGTECH today announced the launch of its unified prediction market platform API,…
Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with approximately 4–5 million patients, with launch planned during 2026QUVIVIQ®…